The migration rate of untreated monocytes from healthy subjects and MS patients toward CCL2 was higher compared to CCL5 and CX3CL1, which confirms previous data also showing higher migration rates of human monocytes toward CCL2 in comparison to CX3CL1 (19). The gene discussed is CCL2; the disease is myeloid sarcoma.